Table 1.

NMR data (400 MHz ¹H, 100 MHz ¹³C, CDCl₃) for 3′-epi-16-hydroxyverrucarin A (1).

Position	δC, type	δH (J in Hz)	NOESY	HMBC
2	79.1, CH	3.86, d (5.1)	13a	5, 12, 13, 14
3α	34.9, CH2	2.48, dd (15.5, 8.2)	11	2, 5, 12
3β		2.26, dt (15.5, 4.7)		2, 4
4	75.5, CH	5.81, dd (8.2, 4.1)	11, 15	2, 5, 6, 12, 11′
5	49.6, C
6	44.7, C
7α	19.7, CH2	1.76, tt (11.7, 2.7)		6, 7, 8, 9, 16
7β		1.91, m	2′	6, 7, 8, 9, 10, 15, 16
8α	23.0, CH2	1.92, m	3′	7, 9, 10
8β		2.06, m		6, 7, 9, 10, 15
9	143.9, C
10	117.5, CH	5.71, d (5.2)		6, 8, 16
11	66.4, CH	3.62, d (5.3)	3α, 4	2, 7, 9, 10, 15
12	65.2, C
13a	47.9, CH2	3.1, d (3.8)	2	2, 5, 12
13b		2.8, d (4.1)	14	2, 5, 12
14	7.4, CH3	0.85, s	13b, 8′	4, 5, 6, 12
15a	63.3, CH2	4.71, d (12.2)	4	5, 6, 7, 11
15b		4.22, d (12.1)	4	5, 6, 7, 1′
16	65.9, CH2	4.07, m		9, 10
1′	174.8, C
2′	74.3, CH	4.13, d (5.7)	7β	1′, 4′, 12′
3′	33.3, CH	2.34, dtd (11.4, 4.3, 2.1)	8α, 8′	4′, 12′
4′a	32.3, CH2	1.9, m	2′	2′, 3′, 5′, 12′
4′b		1.76, tt (11.7, 2.7)		12′
5′a	61.2, CH2	4.49, ddd (11.4, 5.4, 2.5)		3′, 6′
5′b		3.96, td (11.8, 3.3)	12	4′, 6′
6′	165.5, C
7′	127.6, CH	6.04, d (15.7)		6′, 8′
8′	138.8, CH	8.03, dd (15.8, 11.7)	14, 3′	6′, 7′, 9′, 10′
9′	139.2, CH	6.67, t (11.4)		7′, 8′, 11′
10′	125.8, CH	6.14, d (11.0)		8′, 11′
11′	166.2, C
12′	10.1, CH3	0.87, d (6.9)	5′b	2′, 4′